← SynDRA
SAFINAMIDE
SynDRA canonical compound SYN0007443 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | SLC6A3 |
|---|
| Mechanism of action | Monoamine oxidase inhibitor |
|---|
| Indication | Parkinson's Disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- MAOB
- SLC6A3
- MAOA
- Maoa
- Maob
- SCN9A
- Scn1a
- Scn2a
- Scn3a
- Sigmar1
Mechanisms of action (all sources)
- Glutamate inhibitor
- Dopamine uptake inhibitor
- Monoamine oxidase inhibitor
- MAOB INHIBITOR
- Monoamine oxidase B inhibitor
- dopamine reuptake inhibitor
Drug classes
- Monoamine Oxidase-B Inhibitors
- Monoamine Oxidase Type B Inhibitor
- Breast Cancer Resistance Protein Inhibitors
ATC classes
- N04B · DOPAMINERGIC AGENTS
Cross-references
Synonyms
- EMD 1195686
- xadago
- safinamide mesylate
- safinamide mesilate
- safinamide methanesulfonate
- Safinamida
- Xadago
- (S)-2-((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanamide
- Fce 26743
- UNII-90ENL74SIG
- (2S)-2-[[4-[(3-Fluorophenyl)methoxy]phenyl]methylamino]propanamide
- EMD-1195686
- 90ENL74SIG
- CHEMBL396778
- AK-77847
- 2(s)-(4-(3-fluorobenzyloxy)benzylamino)propionamide
- CHEMBL48582
- Safinamide [USAN:INN]
- 2-(4-(3-Fluorobenzyloxy)benzylamino)propionamide
- AC1L2ZLK
- Safinamide (USAN/INN)
- (S)-2-(((4-((3-Fluorophenyl)methoxy)phenyl)methyl)amino)propanamide
- EC 603-772-2
- SCHEMBL69350
- ON 019190.Na
- Fce-26743
- safinamidum
- fbap methanesulfonate
- RefChem:57040
- N04BD03
- DTXCID701436700
- (S)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide
- (S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide
- MFCD00897036
- Safinamide (Standard)
- SAFINAMIDE [MI]
- SAFINAMIDE [INN]
- SAFINAMIDE [USAN]
Look up SAFINAMIDE in the interactive SynDRA portal →